Serum YKL-40 and colorectal cancer
Open accessThe DOI matches its Crossref record.
Abstract
YKL-40 is a mammalian member of the chitinase protein family. Although the function of YKL-40 is unknown, the pattern of its expression suggests a function in remodelling or degradation of extracellular matrix. High serum YKL-40 has been found in patients with recurrent breast cancer and has been related to short survival. In the present study we analysed YKL-40 in preoperative sera from patients with colorectal cancer and evaluated its relation to survival. Serum YKL-40 was determined by RIA in 603 patients. Survival after operation was registered, and median follow-up time was 61 months. Three hundred and forty patients died. Sixteen per cent of the patients with Dukes' A, 26% with Dukes' B, 19% with Dukes' C and 39% with Dukes' D had high serum YKL-40 levels (adjusted for age). Analysis of serum YKL-40 as a continuous variable showed an association between increased serum YKL-40 and short survival (P < 0.0001). Patients with high preoperative serum YKL-40 concentration had significantly shorter survival than patients with normal YKL-40 (HR = 1.7; 95% CI: 1.3-2.1, P < 0.0001). Multivariate Cox analysis including serum YKL-40, serum CEA, Dukes' stage, age and gender showed that high YKL-40 was an independent prognostic variable for short survival (HR = 1.4; 95% CI: 1.1-1.8, P = 0.007). These results suggest that YKL-40 may play an important role in tumour invasion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Chitinase-3 like-protein-1 function and its role in diseases
Zhao, T., Su, Z., Li, Y., Zhang, X., & You, Q. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00303-7 · Cited by 536
Gene expression in papillary thyroid carcinoma reveals highly consistent profiles
Huang, Y., Prasad, M., Lemon, W. J., Hampel, H., Wright, F. A., Kornacker, K., LiVolsi, V., Frankel, W., Kloos, R. T., Eng, C., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251547398 · Cited by 442
Garnero, P., Rousseau, J.-C., & Delmas, P. D. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200005)43:5<953::aid-anr1>3.0.co;2-q · Cited by 409
RECKLIES, A. D., WHITE, C., & LING, H. (2002) · Biochemical Journal · doi:10.1042/bj20020075 · Cited by 388
Serum YKL-40, A New Prognostic Biomarker in Cancer Patients?
Johansen, J. S., Jensen, B. V., Roslind, A., Nielsen, D., & Price, P. A. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0011 · Cited by 339
Self-citationNigro, J. M., Misra, A., Zhang, L., Smirnov, I., Colman, H., Griffin, C., Ozburn, N., Chen, M., Pan, E., Koul, D., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2921 · Cited by 325
Role of YKL-40 in the Angiogenesis, Radioresistance, and Progression of Glioblastoma
Francescone, R. A., Scully, S., Faibish, M., Taylor, S. L., Oh, D., Moral, L., Yan, W., Bentley, B., & Shao, R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.212514 · Cited by 261
Transcriptional Regulation of CHI3L1, a Marker Gene for Late Stages of Macrophage Differentiation
Rehli, M., Niller, H.-H., Ammon, C., Langmann, S., Schwarzfischer, L., Andreesen, R., & Krause, S. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306792200 · Cited by 249
De Ceuninck, F., Gaufillier, S., Bonnaud, A., Sabatini, M., Lesur, C., & Pastoureau, P. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5253 · Cited by 196
Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes
Cantó, E., Tintoré, M., Villar, L. M., Costa, C., Nurtdinov, R., Álvarez-Cermeño, J. C., Arrambide, G., Reverter, F., Deisenhammer, F., Hegen, H., et al. (2015) · Brain · doi:10.1093/brain/awv017 · Cited by 193
“, 2009), colon/ rectum (Cintin et al., 1999), lung (Thom et al.”
BackgroundDiurnal, weekly, and long-time variation in serum concentrations of YKL-40 in healthy subjects
Johansen, J. S., Lottenburger, T., Nielsen, H. J., Jensen, J. E. B., Svendsen, M. N., Kollerup, G., & Christensen, I. J. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2766 · Cited by 72
“Serum YKL-40 is elevated compared with healthy subjects in many patients with primary or metastatic carcinoma of the breast (2), colorectal (3), ovary (4, 5), lung (6), prostate (7), kidney (8), endometrial (9), cervical (10), and head and neck (11), and in patients with glioblastoma (12, 13), melanoma (14, 15), acute…”
BackgroundSelf-citation
Metadata
- Authors
- Cintin, C., Johansen, J. S., Christensen, I. J., Price, P. A., Sørensen, S., & Nielsen, H. J.
- Venue
- British Journal of Cancer
- Published
- 1999-02-26
- Volume
- 79
- Issue
- 9-10
- Pages
- 1494-1499
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2133628830
- Cited by
- 187
- References
- 0
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.